630 related articles for article (PubMed ID: 4950053)
1. Studies on the capacity of neonatal skin grafts to induce tolerance in adult mice.
Wachtel SS; Silvers WK
Adv Biol Skin; 1971; 11():223-31. PubMed ID: 4950053
[No Abstract] [Full Text] [Related]
2. Immune capacity of mice tolerating a weakly incompatible skin allograft. I. Tolerance induction by neonatal skin graft in adult recipients or by neonatal inoculation of adult cells.
Viklický V; Poláckovä M; Wabik B
Folia Biol (Praha); 1975; 21(4):209-18. PubMed ID: 1102343
[TBL] [Abstract][Full Text] [Related]
3. Are histocompatibility antigens in neonatal skin grafts truly tolerogenic?
Polácková M; Svec M; Viklický V
Folia Biol (Praha); 1979; 25(2):95-100. PubMed ID: 378720
[TBL] [Abstract][Full Text] [Related]
4. Importance of chimerism in maintaining tolerance of skin allografts in mice.
Lubaroff DM; Silvers WK
J Immunol; 1973 Jul; 111(1):65-71. PubMed ID: 4576586
[No Abstract] [Full Text] [Related]
5. Comparative study of neonatal and adult skin transplants in mice.
Kowolenko M; Gozzo JJ
Transplantation; 1984 Jul; 38(1):84-6. PubMed ID: 6377617
[No Abstract] [Full Text] [Related]
6. Transplantation immunity evoked by skin homografts and expressed in intact skin.
Billingham RE
Adv Biol Skin; 1971; 11():183-98. PubMed ID: 4146273
[No Abstract] [Full Text] [Related]
7. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
Monaco AP; Wood ML
Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
[No Abstract] [Full Text] [Related]
8. Mechanisms and kinetics of cyclophosphamide-induced specific tolerance to skin allografts in mice.
Nirmul G; Severin C; Taub RN
Transplant Proc; 1973 Mar; 5(1):675-8. PubMed ID: 4572127
[No Abstract] [Full Text] [Related]
9. Some questions of non-H-2 transplantation tolerance in mice.
Nĕmec M; Nouza K
Folia Biol (Praha); 1971; 17(2):86-96. PubMed ID: 4930299
[No Abstract] [Full Text] [Related]
10. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
11. Survival of first and second-set skin allografts in mice and rats under the influence of cysteine.
Ryzewski J; Kossakowska M
Arch Immunol Ther Exp (Warsz); 1974; 22(5):625-8. PubMed ID: 4614758
[No Abstract] [Full Text] [Related]
12. The "Sk" (skin-specific) rejection phenomenon as evidence of the natural role of acquired tolerance.
Steinmuller D; Lofgreen JS
Transplant Proc; 1977 Jun; 9(2):1385-91. PubMed ID: 327636
[No Abstract] [Full Text] [Related]
13. Alteration of skin in Gross leukemia. IV. Test of allograft hypothesis.
Mariani T; Maruyama Y; Good RA
J Natl Cancer Inst; 1972 Sep; 49(3):879-85. PubMed ID: 4567230
[No Abstract] [Full Text] [Related]
14. Effect of immunosuppression and cellular antigen on xenograft survival.
Cerilli J; Gideon L; Hattan D
Transplant Proc; 1970 Dec; 2(4):516-21. PubMed ID: 4939699
[No Abstract] [Full Text] [Related]
15. Skin grafts and allogeneic tumor growth in mice.
Colmerauer ME; Rumi L; Saal F; Pasqualini CD
Medicina (B Aires); 1974; 34(5):471-5. PubMed ID: 4612291
[No Abstract] [Full Text] [Related]
16. Correlation between cellular manifestations of allograft response and graft rejection times.
Viklický V; Polácková M
Folia Biol (Praha); 1974; 20(2):125-32. PubMed ID: 4140110
[No Abstract] [Full Text] [Related]
17. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
Gelfand MC; Nowakowski A; Friedman EA; Knepshield JH
Transplantation; 1971 Nov; 12(5):377-83. PubMed ID: 4948689
[No Abstract] [Full Text] [Related]
18. Pharmacologic control of the hormonally modulated immune response. III. Prolongation of allogeneic skin graft rejection and prevention of runt disease by a combination of drugs acting on neuroendocrine functions.
Pierpaoli W; Maestroni GJ
J Immunol; 1978 May; 120(5):1600-3. PubMed ID: 26719
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic components of weaker histoincompatibility systems in mice.
Hildemann WH; Morgan M; Frautnick L
Transplant Proc; 1970 Mar; 2(1):24-31. PubMed ID: 4940353
[No Abstract] [Full Text] [Related]
20. Tolerance and enhancement in organ transplantation.
Brent L
Transplant Proc; 1972 Sep; 4(3):363-8. PubMed ID: 4404151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
